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217 GLOBAL GENE EXPRESSION PROFILING OF EARLY
OSTEOARTHRITIS IN WILD-TYPE MICE AND MICE LACKING
ADAMTS-5 ACTIVITY
D. Belluoccio1, L. Rowley1, A. Fosang1, C. Little2, J.F. Bateman1.
1Murdoch Childrens Research Institute, Parkville, AUSTRALIA,
2University of Sydney, Sydney, AUSTRALIA
Purpose: To explore the molecular mechanisms of osteoarthritis (OA)
initiation and progression, global gene expression proﬁling was performed
on cartilage from mice with surgically-induced OA. We used WT mice,
and mice lacking ADAMTS-5 activity (ADAMTS-5 Dcat). By comparing
the gene expression during OA in these mice we have distinguished early
events leading to aggrecan degradation (pre-ﬁbrillated changes) from the
downstream progressive phases that follow loss of aggrecan.
Methods: Mechanical instability was introduced into 10 week old male
mouse knee joints by surgical destabilization of the medial meniscus
(DMM). In this model focal degeneration, exempliﬁed by loss of aggrecan
in the non-calciﬁed articular cartilage, occurs in the medial tibial plateau
2 weeks after surgery in WT mice. After 6 weeks, aggrecan loss had
progressed and cartilage ﬁbrillation was evident. In ADAMTS-5 Dcat
mice aggrecan loss and cartilage erosion is signiﬁcantly reduced. Non-
calciﬁed cartilage from the developing lesion in DMM or sham-operated
joints at 1, 2 and 6 weeks post-surgery was harvested by laser microdis-
section. Chondrocyte total RNA was extracted and cRNA generated by
linear ampliﬁcation (MessageAmp, Ambion), labeled with Cy3/Cy5 and
hybridized to 44k whole genome microarrays (Agilent). Data was validated
by quantitative PCR of selected genes.
Results: There was an early upregulation (1 week) in WT mice of carti-
lage hypertrophy markers, such as collagen X. However in the ADAMTS-5
Dcat mice, these were not upregulated until 6 weeks, suggesting that
the hypertrophic response of chondrocytes is not an initiating event,
but an event downstream of the onset of ADAMTS-5 activity and/or
cartilage degeneration. Of particular interest was the upregulation of
the inﬂammatory mediator Ptgs2 (Cox-2) early (1 and 2 weeks) in WT
OA mice. Upregulation of Cox-2 was not seen in ADAMTS-5 Dcat mice.
Dysregulation of several Bmps (eg Bmp7), inﬂammatory cytokines, Fgfs,
members of the Wnt/b-catenin pathway were apparent in WT mice.
Expression proﬁling also showed numerous changes in gene expression
that followed the same pattern in both WT and ADAMTS-5 Dcat mice,
and thus are likely to be independent of ADAMTS-5-mediated aggrecan
degradation. These changes include upregulation of several cathepsins
(eg cathepsin S), Bmps (eg Bmp7) lumican and ﬁbronectin.
Conclusions: This well controlled OA model combined with precise
microdissection of cartilage from developing cartilage lesions and mi-
croarray technology provides new insights into gene expressed during
the initiation and progression of OA. Furthermore the comparison of OA
gene expression in WT, ADAMTS-5 Dcat and other mouse models will
allow us to prioritize candidate genes for functional analysis.
218 GENOME-WIDE COMPARATIVE TRANSCRIPTOME ANALYSIS
OF CARTILAGE FORMATION IN VIVO
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Purpose: The regulation of in vivo chondrogenesis is incompletely un-
derstood, and would be informed by comprehensive analyses of gene
expression. So far however, this goal has been limited by an inability
to access RNA of sufﬁcient quality from in vivo chondrogenic tissues.
In the present study, we set out to generate gene expression proﬁles
representative of key stages of in vivo chondrogenesis.
Methods: Tibial and ﬁbular pre-condensed mesenchyme from 11.5dpc
Swiss White mouse hindlimbs and the corresponding condensations and
cartilage anlagen from 12.5dpc and 13.5dpc mice were micodissected
and total RNA isolated using TRIzol. cRNA was generated by linear
ampliﬁcation (MessageAmp, Ambion), labeled with Cy3 or Cy5 and
hybridized to 44k whole genome oligo microarrays (Agilent). Microarray
data was validated by quantitative PCR of selected genes.
Results: We found signiﬁcant differential expression of 931 genes during
these early stages of chondrogenesis. Of these, 380 genes were down-
regulated and 551 up-regulated. Our studies characterized the expres-
sion pattern of gene families previously associated with chondrogenesis,
such as adhesion molecules, secreted signalling molecules, transcription
factors and extracellular matrix components. Gene ontology approaches
identiﬁed 892 differentially expressed genes not previously identiﬁed
during the initiation of chondrogenesis. These included several Bmp, Gdf,
Wnt, Sox, Fox, Lhx, Robo and Slit family members.
Conclusions: These data represent the ﬁrst global gene expression pro-
ﬁling analysis of chondrogenic tissues during in vivo development. They
identify genes for further study on their functional roles in chondrogenesis,
and provide a comprehensive and important resource for future studies
on cartilage development, disease, and repair.
219 PHASE II ENZYME INDUCER SULFORAPHANE BLOCKS
CATABOLIC PATHWAY IN ARTICULAR CHONDROCYTES
AND INHIBITS MONOIODOACETATE INDUCED
OSTEOARTHRITIS IN RATS
H.A. Kim1, C-K. Chung2, Y. Yeo1, S. Kim1, I. Kim1. 1Hallym University
Sacred Heart Hospital, Anyang, REPUBLIC OF KOREA, 2Seoul
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Purpose: Phase 2 enzyme inducers are recently found to have anti-
inﬂammatory activity in addition to its chemopreventive activity. In the
current study, we examined the inﬂuence of sulforaphan (SFN), one of
the most potent inducer of the phase 2 enzymes on the induction of
nitric oxide (NO) and prostaglandin (PG) E2 in human articular chondro-
cytes. The efﬁcacy of SFN on an animal model of osteoarthritis (OA),
monoiodoacetate (MIA) induced arthritis in rats was also examined.
Methods: Articular cartilages were obtained from knee OA patients and
cultured in monolayer. Chondrocytes were stimulated with interleukin
(IL)-1 or tumor necrosis factor (TNF)-a with or without 1 hour pre-
incubation with SFN. Production of NO and PGE2 was evaluated by
Greiss reaction and enzyme linked immunosorbent assay (ELISA), re-
spectively. The expression of inducible NO synthase and cyclooxygenase
(COX)-2 was evaluated by real time reverse transcriptase-polymerase
chain reaction and Western blot. Knee joints of rats were injected with
3mg of MIA and 10mM of SFN was injected biweekly. The severity of
arthritis was evaluated after 1 and 2 weeks by histological grading of
articular cartilage in SFN-treated and control animals.
Results: SFN signiﬁcantly inhibited the production of NO and PGE2
induced by either Il-1 or TNF-a dose dependently in monolayer cultured
chondrocytes. At the concentration of 10 mM, SFN completely inhibited
both NO and COX-2 at mRNA and protein level. SFN treated rats showed
signiﬁcant inhibition of cartilage degradation at 1 week after MIA injection,
but at 2 weeks, the difference was not signiﬁcant between SFN-treated
and control rats
Conclusions: SFN was found to inhibit NO and PGE2 production
in proinﬂammatory cytokine stimulated chondrocytes and MIA induced
rat OA. Delineation of biochemical mechanism regulating cartilage
catabolism by SFN may identify potentially safe and effective therapeutic
target for inhibition of cartilage degradation in arthritic diseases.
220 EFFECT OF ETANERCEPT ON iNOS, Il-6, AND COX-2 GENE
EXPRESSION IN HUMAN CHONDROCYTES IN VITRO
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Purpose: Erosive osteoarthritis (EOA) is considered as an aggressive
variant of hand OA characterized by a prominent local inﬂammation and
radiographic aspects of central bone erosion on interphalangeal joints.
Cytokines, such as Interleukin (IL)-1b and Tumor Necrosis Factor (TNF)-
a, are involved in the pathophysiology of OA, directly and by stimulation of
synoviocytes and chondrocytes to produce inﬂammatory molecules like
nitric oxide (NO), Il-6 and cyclooxygenase (COX)-2. In inﬂamed joints,
NO is involved in joint destruction by enhancing cytokine production and
suppressing collagen and proteoglycan synthesis while Il-6 is implicated
in bone erosion. Moreover, COX-2 could indirectly affect chondrocytes
metabolism by the production of prostaglandins that mediate pain, sup-
port the inﬂammatory process and inhibit aggrecan synthesis.
The aim of the present study was to investigate the effects of the TNFa-
antagonist etanercept on Il-6, COX-2 and iNOS gene expression in human
chondrocytes
Methods: Primary human chondrocytes were obtained from non-weight
bearing articular cartilage of femoral heads after sequential digestions
with trypsin and collagenase. Chondrocytes were treated with different
